Skip to main content
OpenTrials

Clinical trial condition

PD-L1 Amplified Tumor (9p24.1)

Explore clinical trials studying PD-L1 Amplified Tumor (9p24.1). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

PD-L1 Amplified Tumor (9p24.1) trial results

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

NCT04242199

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Upmc Cancercenter Pittsburgh, Pennsylvania, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View all 21 locations
View Trial Details

Related conditions